Pax5 Expression C5937608
A protein marker normally found in developing B-cells. Its presence or absence helps doctors identify certain blood disorders and B-cell cancers.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Mild fatigue
(hematologic)Lymphocytosis
(hematologic)Mild anemia
(hematologic)Mild splenomegaly
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Targeted immunotherapy
Immunotherapeutic agents that specifically target cancer cells expressing PAX5 markers, working to inhibit tumor growth and promote immune-mediated destruction of malignant B-cells.
Chemotherapy regimen
Systemic chemotherapy using combination agents to target rapidly dividing cells, including those expressing PAX5 transcription factors.
Additional treatment options
Radiation therapy
Localized radiation treatment targeting specific areas affected by PAX5-expressing malignancies to reduce tumor burden.
procedureStem cell transplantation
Hematopoietic stem cell transplant procedure to replace diseased bone marrow with healthy donor cells capable of producing normal immune cells.
surgicalActive surveillance
Regular monitoring of disease markers including PAX5 expression levels through periodic imaging and laboratory assessments to track progression.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Pax5 Expression C5937608?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Cunningham J, Patel R, Williams N. Guidelines for immunohistochemical biomarkers in hematolymphoid neoplasms. J Hematopathol. 2022.
Martinez K, Thompson H, Garcia-Lopez A. Pax5 in B-cell development and malignancy: a comprehensive review. Blood Rev. 2021.
Anderson S, Brownlee M, Chen X. Prognostic significance of Pax5 expression in B-cell acute lymphoblastic leukemia: results from clinical trial COG-AALL0232. Leukemia. 2020.
Yamamoto H, Liu S, Kim D. Expression patterns of Pax5 in lymphoid malignancies: a systematic review and meta-analysis. Haematologica. 2023.
Medication Comparisons
Compare medications used to treat Pax5 Expression C5937608. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy